Page last updated: 2024-09-04

cirsilineol and Lung Injury, Acute

cirsilineol has been researched along with Lung Injury, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ai, M; Li, L; Li, Y; Lin, S; Wu, T; Yang, N; Zhang, M	1

Other Studies

1 other study(ies) available for cirsilineol and Lung Injury, Acute

Article	Year
Cirsilineol attenuates LPS-induced inflammation in both in vivo and in vitro models via inhibiting TLR-4/NFkB/IKK signaling pathway. Journal of biochemical and molecular toxicology, 2021, Volume: 35, Issue:8 Topics: Acute Lung Injury; Animals; Disease Models, Animal; Flavones; I-kappa B Kinase; Inflammation; Lipopolysaccharides; Male; Mice; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4	2021

Article

Year

Cirsilineol attenuates LPS-induced inflammation in both in vivo and in vitro models via inhibiting TLR-4/NFkB/IKK signaling pathway.

Journal of biochemical and molecular toxicology, 2021, Volume: 35, Issue:8

Topics: Acute Lung Injury; Animals; Disease Models, Animal; Flavones; I-kappa B Kinase; Inflammation; Lipopolysaccharides; Male; Mice; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4

2021